Rx Propellant is scaling up in Genome Valley with a USD 100 million investment in a new life sciences campus. The move strengthens Hyderabad’s global biotech standing and meets rising demand for advanced lab space.
Teva and Sanofi reveal duvakitug’s 44-week success, showing lasting remission in ulcerative colitis and Crohn’s patients, reinforcing TL1A as a promising treatment target.
Aster Volunteers launches two new Mobile Medical Units in Tirupati and Anekal, expanding healthcare access in underserved communities across India.
Eli Lilly’s Retevmo delivers significant gains in event-free survival for early-stage RET fusion-positive NSCLC, marking a breakthrough in targeted lung cancer therapy.
Lupin partners with Spektus Pharma to launch DeslaFlex in Canada, enhancing its CNS portfolio and offering patients a novel treatment option for Major Depressive Disorder.
Courage met opportunity in Haridwar as Akums hosted a three-day skill camp for acid attack and burn survivors, helping them step into corporate life with confidence and purpose.
The USFDA has completed its inspection of Enzene’s manufacturing unit in Chakan, Pune, issuing six procedural observations with no data integrity issues. The outcome strengthens the company’s compliance standing in regulated markets.
Indian pharma leaders Sun Pharma and Glenmark are adopting AI in drug discovery to reduce costs, accelerate R&D timelines, and move from generics toward innovative medicines.
Entod Pharmaceuticals has introduced Colladerm, the first AI bio-engineered collagen transdermal gel serum, in the 54 th National Conference of Indian Association of Dermatologists
Sanofi Healthcare India has expanded its Hyderabad Global Capability Centre, increasing capacity to 4,500 employees. Backed by a multi-hundred-million-dollar investment, the move strengthens India’s role in Sanofi’s global operations.